Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cantor Fitzgerald
Argus Health
Cipla
AstraZeneca
Express Scripts
Covington
Deloitte
Merck

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,308,264

« Back to Dashboard

Summary for Patent: 4,308,264
Title: Stabilized, dilute aqueous preparation of 1.alpha.,25-dihydroxycholecalciferol for neonatal administration
Abstract:1.alpha.,25-Dihydroxycholecalciferol, also known as 1.alpha.,25-dihydroxyvitamin D.sub.3, calcitriol or 1.alpha.,25(OH).sub.2 D.sub.3, occurs naturally in man as the active form of cholecalciferol or vitamin D.sub.3. The natural supply of vitamin D.sub.3 depends on the conversion of 7-dehydrocholesterol to vitamin D.sub.3 in the skin by ultraviolet light. Vitamin D.sub.3 is then converted to calcitriol in a two-step process in the liver and kidney before its acts on its target tissue.
Inventor(s): Conway; Nancy M. (Mundelein, IL), Krimen; Lewis I. (Lake Bluff, IL)
Assignee: Abbott Laboratories (North Chicago, IL)
Application Number:06/228,870
Patent Claim Types:
see list of patent claims
Use; Compound; Dosage form; Composition; Formulation; Process;

Drugs Protected by US Patent 4,308,264

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,308,264

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 1174605 ➤ Try a Free Trial
Australia 7961382 ➤ Try a Free Trial
Australia 549765 ➤ Try a Free Trial
France 2498450 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Teva
Accenture
Citi
Fuji
US Army
Harvard Business School
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.